New Search

Advanced search
Export article
Open Access

Prognostic significance and biological function of Lamina-associated polypeptide 2 in non-small-cell lung cancer.

Chang Liu, Hui Yu, Xuxia Shen, Jie Qiao, Xianghua Wu, Jianhua Chang, Xunxia Zhu, Sciprofile linkJialei Wang, Xiaoyong Shen
Published: 16 May 2019
OncoTargets and Therapy , Volume 12, pp 3817-3827; doi:10.2147/OTT.S179870

Abstract: Purpose: Lamina-associated polypeptide 2 (LAP2; encoded by TMPO), is a nuclear protein that may affect chromatin regulation and gene expression through dynamically binding to nuclear lamin. TMPO (LAP2) plays dual roles of either suppressing or promoting proliferation of cells, depending on the status of the cell. It has been reported that TMPO is up-regulated in various cancer types. However, its function in lung cancer has not been studied yet. Materials and methods: A series of clinical microarray datasets for lung cancer were investigated to demonstrate the expression of TMPO. The transcription of TMPO gene in human lung cancer was analyzed using Oncomine platform ( according to the standardized procedures described previously. Four separate datasets (Hou Lung, Okayama Lung, Beer Lung, and Garber Lung) were analyzed. Results: Here, we show that TMPO is over-expressed in lung cancer tissues, and that a high level of TMPO indicates a poor prognosis in lung cancer patients. Knockdown of TMPO in lung cancer cells inhibits cell proliferation and induces apoptosis. Also, down-regulation of TMPO leads to an impaired metastatic ability of tumor cells. A nude mice tumor model show that knockdown of TMPO suppresses tumor formation in vivo. Conclusion: Collectively, this study suggests TMPO as an oncogene and a novel prognostic gene in lung cancer.
Keywords: non-small-cell lung cancer / Oncogene / Lap2 / prognostic factor / Tmpo

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

Share this article

Click here to see the statistics on "OncoTargets and Therapy" .
Back to Top Top